{ "article": { "LEGIARTI000022782323": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "R5521-1", "ETAT": "MODIFIE", "TYPE": "AUTONOME", "DATE_FIN": "2018-08-01", "DATE_DEBUT": "2010-09-03" } }, "META_COMMUN": { "ID": "LEGIARTI000022782323", "URL": "article/LEGI/ARTI/00/00/22/78/23/LEGIARTI000022782323.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGIARTI000022779758", "@num": "2", "#text": "Décret n°2010-1031\n du 31 août 2010 - art. 2", "@sens": "cible", "@cidtexte": "JORFTEXT000022778936", "@nortexte": "SASP1012541D", "@numtexte": "2010-1031", "@typelien": "CREE", "@naturetexte": "DECRET", "@datesignatexte": "2010-08-31" }, { "@id": "LEGIARTI000006914726", "@num": "R5121-11", "#text": "Code de la santé publique - art. R5121-11", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CITATION", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000006914744", "@num": "R5121-21", "#text": "Code de la santé publique - art. R5121-21", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CITATION", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000006914748", "@num": "R5121-25", "#text": "Code de la santé publique - art. R5121-25", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CITATION", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000018774525", "@num": "R5121-37-2", "#text": "Code de la santé publique - art. R5121-37-2", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CITATION", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "TM": { "TM": { "TM": { "TM": { "TM": { "TITRE_TM": [ { "@id": "LEGISCTA000022782329", "@fin": "2999-01-01", "#text": "Chapitre Ier : Produits pharmaceutiques", "@debut": "2010-09-03" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000022782331", "@fin": "2999-01-01", "#text": "Titre II : Îles Wallis et Futuna", "@debut": "2010-09-03" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000022782333", "@fin": "2999-01-01", "#text": "Livre V : Mayotte, Îles Wallis et Futuna et Terres australes et antarctiques françaises, Nouvelle-Calédonie et Polynésie française", "@debut": "2010-09-03" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006132399", "@fin": "2999-01-01", "#text": "Cinquième partie : Produits de santé", "@debut": "2004-07-29" } ] }, "TITRE_TM": [ { "@id": "LEGISCTA000006112927", "@fin": "2999-01-01", "#text": "Partie réglementaire", "@debut": "2000-12-23" } ] }, "@cid": "LEGITEXT000006072665", "@nature": "CODE", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Code de la santé publique", "@debut": "1953-10-07", "@id_txt": "LEGITEXT000006072665", "@c_titre_court": "Code de la santé publique" } ], "@date_publi": "2999-01-01", "@date_signature": "2999-01-01" } }, "VERSIONS": { "VERSION": [ { "@etat": "MODIFIE", "LIEN_ART": { "@id": "LEGIARTI000022782323", "@fin": "2018-08-01", "@num": "R5521-1", "@etat": "MODIFIE", "@debut": "2010-09-03", "@origine": "LEGI" } }, { "@etat": "VIGUEUR", "LIEN_ART": { "@id": "LEGIARTI000037269752", "@fin": "2999-01-01", "@num": "R5521-1", "@etat": "VIGUEUR", "@debut": "2018-08-01", "@origine": "LEGI" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "Les articles R. 5121-11, R. 5121-21, les premier et quatrième alinéas de l'article R. 5121-25 et l'article R. 5121-37-2 sont applicables à Wallis et Futuna." } }, "LEGIARTI000022779758": { "META": { "META_SPEC": { "META_ARTICLE": { "NUM": "2", "TYPE": "ENTIEREMENT_MODIF", "DATE_FIN": "2999-01-01", "DATE_DEBUT": "2999-01-01" } }, "META_COMMUN": { "ID": "LEGIARTI000022779758", "URL": "article/LEGI/ARTI/00/00/22/77/97/LEGIARTI000022779758.xml", "NATURE": "Article", "ORIGINE": "LEGI" } }, "LIENS": { "LIEN": [ { "@id": "LEGISCTA000022782329", "#text": "Code de la santé publique - Chapitre Ier : Produits pharmaceutiques (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGISCTA000022782333", "#text": "Code de la santé publique - Livre V : Mayotte, Îles Wallis et Futuna et Ter... (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGISCTA000022782331", "#text": "Code de la santé publique - Titre II : Îles Wallis et Futuna (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000022782335", "@num": "R1521-3", "#text": "Code de la santé publique - art. R1521-3 (V)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" }, { "@id": "LEGIARTI000022782323", "@num": "R5521-1", "#text": "Code de la santé publique - art. R5521-1 (M)", "@sens": "source", "@cidtexte": "LEGITEXT000006072665", "@typelien": "CREE", "@naturetexte": "CODE", "@datesignatexte": "2999-01-01" } ] }, "CONTEXTE": { "TEXTE": { "@cid": "JORFTEXT000022778936", "@nor": "SASP1012541D", "@num": "2010-1031", "@nature": "DECRET", "TITRE_TXT": [ { "@fin": "2999-01-01", "#text": "Décret n° 2010-1031 du 31 août 2010 relatif aux programmes d'apprentissage et pris en application de l'article L. 1161-5 du code de la santé publique", "@debut": "2999-01-01", "@id_txt": "JORFTEXT000022778936", "@c_titre_court": "Décret n°2010-1031 du 31 août 2010" }, { "@fin": "2999-01-01", "#text": "Décret n° 2010-1031 du 31 août 2010 relatif aux programmes d'apprentissage et pris en application de l'article L. 1161-5 du code de la santé publique", "@debut": "2010-09-03", "@id_txt": "LEGITEXT000022779750", "@c_titre_court": "Décret n°2010-1031 du 31 août 2010" } ], "@ministere": "Ministère de la santé et des sports", "@date_publi": "2010-09-02", "@date_signature": "2010-08-31", "@num_parution_jo": "0203" } }, "VERSIONS": { "VERSION": [ { "LIEN_ART": { "@id": "LEGIARTI000022779758", "@fin": "2999-01-01", "@num": "2", "@debut": "2999-01-01", "@origine": "LEGI" } }, { "LIEN_ART": { "@id": "JORFARTI000022778949", "@fin": "2999-01-01", "@num": "2", "@debut": "2999-01-01", "@origine": "JORF" } } ] }, "BLOC_TEXTUEL": { "CONTENU": "
A créé les dispositions suivantes :

- Code de la santé publique
\n Sct. Livre V : Mayotte, Îles Wallis et Futuna et Terres Australes et Antarctiques françaises, Nouvelle-Calédonie et Polynésie française, Sct. Titre II : Îles Wallis et Futuna, Sct. Chapitre Ier : Produits pharmaceutiques, Art. R5521-1\n
\n

\n
\n
\n
A modifié les dispositions suivantes :

- Code de la santé publique
Art. R1521-3
\n

\n
" } } }, "article_lien": [ { "article_id": "LEGIARTI000022779758", "cible": false, "cidtexte": "LEGITEXT000006072665", "id": "LEGIARTI000022782323", "typelien": "CREE" } ], "follow": [ "LIENS.LIEN[@sens=cible,@typelien=CREATION].@id" ], "id": "LEGIARTI000022782323", "liens_entrants": true }

Article R5521-1 AUTONOME MODIFIE, en vigueur du 03/09/2010 au 01/08/2018 (Code de la santé publique)